Literature DB >> 15527696

Glucocorticoid excess and hypertension.

Smita Baid1, Lynnette K Nieman.   

Abstract

Cushing's syndrome is a rare disorder characterized by chronic, excess glucocorticoid exposure. Hypertension is one of the most discriminating features of the disease, as it is present in 80% of patients. Patients with Cushing's syndrome have a mortality rate four times that of the general population, most likely secondary to an increased number of cardiovascular risk factors, including hypertension. In this article, we review several pathogenetic mechanisms of glucocorticoid-induced hypertension, including the role of sodium/water and mineralocorticoid excess, as well as involvement of the vasculature and kidney. Although treatment of hypertension with available antihypertensive medications is only moderately successful, after cure of Cushing's syndrome, approximately 30% of patients have persistent hypertension.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15527696     DOI: 10.1007/s11906-004-0046-0

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  52 in total

1.  Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure.

Authors:  D A Scheuer; A G Bechtold
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-06       Impact factor: 3.619

2.  24-hour profiles of blood pressure and heart rate in Cushing's syndrome. Evidence for differential control of cardiovascular variables by glucocorticoids.

Authors:  M Panarelli; M Terzolo; A Piovesan; G Osella; P Paccotti; G Pinna; A Angeli
Journal:  Ann Ital Med Int       Date:  1990 Jan-Mar

3.  Losartan in Cushing's syndrome.

Authors:  S Zacharieva; M Orbetzova; E Natchev; J Vergilova; M Andrewa; M Wipperrnann; S Torbova; D Tzingilev; P Angelova-Gateva
Journal:  Methods Find Exp Clin Pharmacol       Date:  1998-03

Review 4.  Hormones and hypertension.

Authors:  R Fraser; D L Davies; J M Connell
Journal:  Clin Endocrinol (Oxf)       Date:  1989-12       Impact factor: 3.478

5.  Cushing's syndrome--killing disease: discriminatory value of signs and symptoms aiding early diagnosis.

Authors:  E J Ross; D C Linch
Journal:  Lancet       Date:  1982-09-18       Impact factor: 79.321

6.  Influence of aldosterone vs. endothelin receptor antagonism on renovascular function in liquorice-induced hypertension.

Authors:  T Quaschning; F Ruschitzka; B Niggli; C M Lunt; S Shaw; M Christ; M Wehling; T F Lüscher
Journal:  Nephrol Dial Transplant       Date:  2001-11       Impact factor: 5.992

7.  Blunted vascular and renal effects of exogenous atrial natriuretic peptide in patients with cushing's disease.

Authors:  C Sala; B Ambrosi; A Morganti
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

8.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

9.  The effect of Enalapril on PGI(2) and NO levels in hypertensive patients.

Authors:  G Di Girolamo; E González; D Livio; A R de los Santos; M L Martí; M A F de Gimeno
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2002 May-Jun       Impact factor: 4.006

Review 10.  Hypertension and the cortisol-cortisone shuttle.

Authors:  Marcus Quinkler; Paul M Stewart
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

View more
  15 in total

1.  Extensive and largely reversible ischemic cerebral infarctions in a prepubertal child with hypertension and Cushing disease.

Authors:  Jil Huong Nguyen; Maya B Lodish; Nicholas J Patronas; Figen Ugrasbul; Margaret F Keil; Mary D Roberts; Jadranka Popovic; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-01       Impact factor: 5.958

Review 2.  Glucocorticoid-induced hypertension.

Authors:  Julie E Goodwin; David S Geller
Journal:  Pediatr Nephrol       Date:  2011-07-09       Impact factor: 3.714

3.  Cushing's syndrome: all variants, detection, and treatment.

Authors:  Susmeeta T Sharma; Lynnette K Nieman
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

4.  A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis.

Authors:  Ravi Suppiah; Andrew Judge; Rajbir Batra; Oliver Flossmann; Lorraine Harper; Peter Höglund; M Kassim Javaid; David Jayne; Chetan Mukhtyar; Kerstin Westman; John C Davis; Gary S Hoffman; W Joseph McCune; Peter A Merkel; E William St Clair; Philip Seo; Robert Spiera; John H Stone; Raashid Luqmani
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

Review 5.  Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.

Authors:  G Arnaldi; T Mancini; G Tirabassi; L Trementino; M Boscaro
Journal:  J Endocrinol Invest       Date:  2012-04       Impact factor: 4.256

Review 6.  Hypercortisolism in obesity-associated hypertension.

Authors:  Amy G Varughese; Oksana Nimkevych; Gabriel I Uwaifo
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

7.  Blood pressure in pediatric patients with Cushing syndrome.

Authors:  Maya B Lodish; Ninet Sinaii; Nicholas Patronas; Dalia L Batista; Meg Keil; Jonelle Samuel; Jason Moran; Somya Verma; Jadranka Popovic; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-03-17       Impact factor: 5.958

8.  Reversible posterior encephalopathy syndrome associated with micronodular adrenocortical disease and Cushing syndrome.

Authors:  Maya Lodish; Nicholas J Patronas; Constantine A Stratakis
Journal:  Eur J Pediatr       Date:  2009-05-05       Impact factor: 3.183

Review 9.  Polypharmacy in Older Adults With Hypertension: A Comprehensive Review.

Authors:  Bertrand N Mukete; Keith C Ferdinand
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-27       Impact factor: 3.738

10.  Estrogen impairs glucocorticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus.

Authors:  M J Weiser; R J Handa
Journal:  Neuroscience       Date:  2009-01-07       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.